Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma
Clinical trial NCT00080353 · COMPLETED
Trial details
- NCT number
- NCT00080353
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.